Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study

[1]  Jun Yao,et al.  Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia , 2017, Psychiatry and clinical neurosciences.

[2]  Jonathan Green,et al.  Sex bias in autism spectrum disorder in neurofibromatosis type 1 , 2016, Journal of Neurodevelopmental Disorders.

[3]  N. Neff,et al.  Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq , 2016, Nature.

[4]  Ashley M. Wilson,et al.  Infection and characterization of Toxoplasma gondii in human induced neurons from patients with brain disorders and healthy controls. , 2016, Microbes and infection.

[5]  Ashley M. Wilson,et al.  Enhanced conversion of induced neuronal cells (iN cells) from human fibroblasts: Utility in uncovering cellular deficits in mental illness-associated chromosomal abnormalities , 2015, Neuroscience Research.

[6]  J. Rapoport,et al.  Clinical utility of neuronal cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopathy. , 2015, Current molecular medicine.

[7]  T. Jongens,et al.  Modulation of cAMP and Ras Signaling Pathways Improves Distinct Behavioral Deficits in a Zebrafish Model of Neurofibromatosis Type 1 , 2014, Cell reports.

[8]  A. Sawa,et al.  Human Stem Cells and Surrogate Tissues for Basic and Translational Study of Mental Disorders , 2014, Biological Psychiatry.

[9]  R. Emsley,et al.  Neurofibromatosis Type 1 and Autism Spectrum Disorder , 2013, Pediatrics.

[10]  R. Emsley,et al.  Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population‐based study , 2013, Developmental medicine and child neurology.

[11]  F. Castellanos,et al.  Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1 , 2013, Developmental medicine and child neurology.

[12]  S. Huson,et al.  Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence , 2013, Developmental medicine and child neurology.

[13]  S. Peltonen,et al.  The pathoetiology of neurofibromatosis 1. , 2011, The American journal of pathology.

[14]  Stephan C. J. Huijbregts,et al.  Does Cognitive Impairment Explain Behavioral and Social Problems of Children with Neurofibromatosis Type 1? , 2010, Behavior genetics.

[15]  B. L. Caputto,et al.  Growth of Peripheral and Central Nervous System Tumors Is Supported by Cytoplasmic c-Fos in Humans and Mice , 2010, PloS one.

[16]  Thomas Vierbuchen,et al.  Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.

[17]  L. Oppenheim.  A Twenty-First Century Perspective on a Play by Samuel Beckett , 2008 .

[18]  B. Moore,et al.  Social, emotional, and behavioral functioning of children with NF1 , 2007, American journal of medical genetics. Part A.

[19]  R. Ferner.  Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective , 2007, The Lancet Neurology.

[20]  Belinda Barton Ba and,et al.  Social skills of children with neurofibromatosis type 1 , 2007 .

[21]  B. Séraphin,et al.  Identification and characterization of human Mex-3 proteins, a novel family of evolutionarily conserved RNA-binding proteins differentially localized to processing bodies , 2007, Nucleic acids research.

[22]  D. Gutmann,et al.  Neurofibromin Regulates Neural Stem Cell Proliferation, Survival, and Astroglial Differentiation In Vitro and In Vivo , 2005, The Journal of Neuroscience.

[23]  P. Angel,et al.  AP-1 subunits: quarrel and harmony among siblings , 2004, Journal of Cell Science.

[24]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[25]  L. Papucci,et al.  Identification of TINO , 2004, Journal of Biological Chemistry.

[26]  Kevin A Roth,et al.  Bcl-2 family regulation of neuronal development and neurodegeneration. , 2004, Biochimica et biophysica acta.

[27]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[28]  J. Tsien,et al.  c-fos regulates neuronal excitability and survival , 2002, Nature Genetics.

[29]  Yinghua Zhu,et al.  Neurofibromin regulates G protein–stimulated adenylyl cyclase activity , 2002, Nature Neuroscience.

[30]  P. Stoeckle,et al.  Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements. , 2001, RNA.

[31]  A. Lovell,et al.  Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions. , 1999, The Journal of pediatrics.

[32]  K. Shannon,et al.  Hyperactive Ras as a therapeutic target in neurofibromatosis type 1. , 1999, American journal of medical genetics.

[33]  D. Green,et al.  Withdrawal of Survival Factors Results in Activation of the JNK Pathway in Neuronal Cells Leading to Fas Ligand Induction and Cell Death , 1999, Molecular and Cellular Biology.

[34]  R. Douglas Fields,et al.  Action Potential-Dependent Regulation of Gene Expression: Temporal Specificity in Ca2+, cAMP-Responsive Element Binding Proteins, and Mitogen-Activated Protein Kinase Signaling , 1997, The Journal of Neuroscience.

[35]  C. Y. Chen,et al.  Selective degradation of early-response-gene mRNAs: functional analyses of sequence features of the AU-rich elements , 1994, Molecular and cellular biology.

[36]  Robert M. Post,et al.  Programmed cell death: Implications for neuropsychiatric disorders , 1994, Biological Psychiatry.

[37]  S. Korsmeyer,et al.  bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. , 1994, Development.

[38]  N. Harada,et al.  Bcl-2 gene is highly expressed during neurogenesis in the central nervous system. , 1993, Biochemical and biophysical research communications.

[39]  Harold C. Sox,et al.  National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making , 1988 .

[40]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[41]  M. Kathleen Kerr,et al.  Linear Models for Microarray Data Analysis: Hidden Similarities and Differences , 2003, J. Comput. Biol..

[42]  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. , 1988, Archives of neurology.